NanoViricides
NNVC
#10170
Rank
โ‚น1.71 B
Marketcap
โ‚น79.48
Share price
3.53%
Change (1 day)
-26.23%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: โ‚น1.71 Billion

As of February 2026 NanoViricides has a market cap of โ‚น1.71 Billion. This makes NanoViricides the world's 10170th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น1.71 B-25.6%
2025โ‚น2.30 B24.8%
2024โ‚น1.84 B85.1%
2023โ‚น0.99 B-6.47%
2022โ‚น1.06 B-66.58%
2021โ‚น3.19 B42.55%
2020โ‚น2.23 B223.11%
2019โ‚น0.69 B-28.72%
2018โ‚น0.97 B-72.69%
2017โ‚น3.55 B-15.9%
2016โ‚น4.23 B-6.67%
2015โ‚น4.53 B-53.5%
2014โ‚น9.75 B-34.29%
2013โ‚น14.83 B262.22%
2012โ‚น4.09 B-14.99%
2011โ‚น4.81 B-47.29%
2010โ‚น9.14 B75.73%
2009โ‚น5.20 B8.9%
2008โ‚น4.77 B161.96%
2007โ‚น1.82 B

End of Day market cap according to different sources

On Feb 6th, 2026 the market cap of NanoViricides was reported to be:

โ‚น1.75 Billion
by Nasdaq info icon info icon
โ‚น1.71 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
โ‚น17.089 T 996,848.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น27.505 T 1,604,490.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น11.397 T 664,783.48%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น10.915 T 636,668.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
โ‚น121.07 B 6,963.23%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น142.92 B 8,237.57%๐Ÿ‡บ๐Ÿ‡ธ USA